Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Environmental conditions and serotype affect Listeria monocytogenes susceptibility to phage treatment in a laboratory cheese model.

Henderson LO, Cabrera-Villamizar LA, Skeens J, Kent D, Murphy S, Wiedmann M, Guariglia-Oropeza V.

J Dairy Sci. 2019 Nov;102(11):9674-9688. doi: 10.3168/jds.2019-16474. Epub 2019 Aug 30.

PMID:
31477293
2.

Identification of Novel Mobilized Colistin Resistance Gene mcr-9 in a Multidrug-Resistant, Colistin-Susceptible Salmonella enterica Serotype Typhimurium Isolate.

Carroll LM, Gaballa A, Guldimann C, Sullivan G, Henderson LO, Wiedmann M.

MBio. 2019 May 7;10(3). pii: e00853-19. doi: 10.1128/mBio.00853-19.

3.

Proficiency testing of human leukocyte antigen-DR and human leukocyte antigen-DQ genetic risk assessment for type 1 diabetes using dried blood spots.

Dantonio P, Meredith-Molloy N, Hagopian WA, She JX, Akolkar B, Cordovado SK, Hendrix M, Henderson LO, Hannon WH, Vogt RF.

J Diabetes Sci Technol. 2010 Jul 1;4(4):929-41.

4.

Glutamic acid decarboxylase and IA-2 autoantibodies in type 1 diabetes: comparing sample substrates for autoantibody determinations.

Wasserfall C, Atkinson M, Jodoin E, Schatz D, She JX, Henderson LO, Ellis T.

Pediatr Diabetes. 2000 Mar;1(1):10-6.

PMID:
15016237
5.

Newborn screening and type 1 diabetes: historical perspective and current activities at the CDC Division of Laboratory Sciences.

Vogt RF Jr, Meredith N, Henderson LO, Hannon WH.

Diabetes Technol Ther. 2003;5(6):1017-21. No abstract available.

PMID:
14709205
6.

Fructosamine monitoring in patients with diabetes: is there a need?

Henderson LO, Vogt RF Jr.

Diabetes Technol Ther. 1999 Winter;1(4):461-2. No abstract available.

PMID:
11474833
7.

Current activities at the Centers for Disease Control and Prevention's National Diabetes Laboratory.

Sampson EJ, Barr JR, Cordovado SK, Hannon WH, Henderson LO, Johnson AB, Miller D, Mueller PW, Myers GL, Pirkle JL, Schleicher RL, Steinberg K, Sussman D, Vogt RF.

Diabetes Technol Ther. 1999 Winter;1(4):403-9.

PMID:
11474824
8.

Fluorescence intensity calibration for immunophenotyping by flow cytometry.

Vogt RF Jr, Whitfield WE, Henderson LO, Hannon WH.

Methods. 2000 Jul;21(3):289-96.

PMID:
10873483
9.

Serum immunoglobulins and lymphocyte subset distributions in children and adults living in communities assessed for lead and cadmium exposure.

Sarasua SM, Vogt RF, Henderson LO, Jones PA, Lybarger JA.

J Toxicol Environ Health A. 2000 May 12;60(1):1-15.

PMID:
10832614
10.

Titration of a CD45-FITC conjugate to determine the linearity and dynamic range of fluorescence intensity measurements on lymphocytes.

Powell MK, Whitfield W, Redelman D, Henderson LO, Vogt RF Jr.

Cytometry. 1998 Oct 1;33(2):219-24.

PMID:
9773883
11.

Terminology and nomenclature for standardization in quantitative fluorescence cytometry.

Henderson LO, Marti GE, Gaigalas A, Hannon WH, Vogt RF Jr.

Cytometry. 1998 Oct 1;33(2):97-105.

PMID:
9773869
12.

An evaluation of the use of dried blood spots from newborn screening for monitoring the prevalence of cocaine use among childbearing women.

Henderson LO, Powell MK, Hannon WH, Bernert JT Jr, Pass KA, Fernhoff P, Ferre CD, Martin L, Franko E, Rochat RW, Brantley MD, Sampson E.

Biochem Mol Med. 1997 Aug;61(2):143-51.

PMID:
9259979
13.

Isotope dilution--mass spectrometric quantification of specific proteins: model application with apolipoprotein A-I.

Barr JR, Maggio VL, Patterson DG Jr, Cooper GR, Henderson LO, Turner WE, Smith SJ, Hannon WH, Needham LL, Sampson EJ.

Clin Chem. 1996 Oct;42(10):1676-82.

14.

Analysis of benzoylecgonine in dried blood spots by liquid chromatography--atmospheric pressure chemical ionization tandem mass spectrometry.

Sosnoff CS, Ann Q, Bernert JT Jr, Powell MK, Miller BB, Henderson LO, Hannon WH, Fernhoff P, Sampson EJ.

J Anal Toxicol. 1996 May-Jun;20(3):179-84.

PMID:
8735199
15.

Two-dimensional protein electrophoresis and multiple hypothesis testing to detect potential serum protein biomarkers in children with fetal alcohol syndrome.

Robinson MK, Myrick JE, Henderson LO, Coles CD, Powell MK, Orr GA, Lemkin PF.

Electrophoresis. 1995 Jul;16(7):1176-83.

PMID:
7498162
16.

Method-dependent variations in the stability of apolipoprotein B in a stabilized liquid reference material.

Mei JV, Powell MK, Henderson LO, Smith SJ, Cooper GR, Marcovina SM, Hannon WH.

Clin Chem. 1994 May;40(5):716-22.

19.

Lymphocyte immunophenotyping with extended quantitative analysis of list-mode files for epidemiologic health studies.

Vogt RF Jr, Henderson LO, Ethridge SF, Huang EY, White JT, Meredith NK.

Ann N Y Acad Sci. 1993 Mar 20;677:462-4. No abstract available.

PMID:
8494243
20.

Radioimmunoassay screening of dried blood spot materials for benzoylecgonine.

Henderson LO, Powell MK, Hannon WH, Miller BB, Martin ML, Hanzlick RL, Vroon D, Sexson WR.

J Anal Toxicol. 1993 Jan-Feb;17(1):42-7.

PMID:
8429627
21.

Clinical applications and standardization of apolipoprotein measurements in the diagnostic workup of lipid disorders.

Cooper GR, Henderson LO, Smith SJ, Hannon WH.

Clin Chem. 1991 May;37(5):619-20. No abstract available.

22.

Establishment of reference methods for lipids, lipoproteins and apolipoproteins.

Cooper GR, Myers GL, Henderson LO.

Eur J Clin Chem Clin Biochem. 1991 Apr;29(4):269-75.

PMID:
1651118
23.

Interlaboratory study of cellular fluorescence intensity measurements with fluorescein-labeled microbead standards.

Vogt RF Jr, Cross GD, Phillips DL, Henderson LO, Hannon WH.

Cytometry. 1991;12(6):525-36.

24.

Impact of protein measurements on standardization of assays of apolipoproteins A-I and B1.

Henderson LO, Powell MK, Smith SJ, Hannon WH, Cooper GR, Marcovina SM.

Clin Chem. 1990 Nov;36(11):1911-7.

25.
26.

Chlorinated hydrocarbon levels in human serum: effects of fasting and feeding.

Phillips DL, Pirkle JL, Burse VW, Bernert JT Jr, Henderson LO, Needham LL.

Arch Environ Contam Toxicol. 1989 Jul-Aug;18(4):495-500.

PMID:
2505694
27.
28.
29.
30.

Preparation of lyophilized human serum based reference materials with graded levels of apolipoproteins A-I and B.

Henderson LO, Hazlehurst JS, Taylor L, Hannon WH.

Clin Biochem. 1988 Aug;21(4):219-23.

PMID:
3136957
31.

An evaluation of the trends in analytical performance of international apolipoprotein A-1 and B assays.

Smith SJ, Henderson LO, Cooper GR, Hannon WH.

Clin Chem. 1988 Aug;34(8):1644-6.

32.

Distribution of 2,3,7,8-tetrachlorodibenzo-p-dioxin in human whole blood and its association with, and extractability from, lipoproteins.

Henderson LO, Patterson DG Jr.

Bull Environ Contam Toxicol. 1988 Apr;40(4):604-11. No abstract available.

PMID:
3370354
33.

Standardization of apolipoprotein measurements.

Cooper GR, Smith SJ, Henderson LO, Hannon WH.

Prog Clin Biol Res. 1988;255:155-74. No abstract available.

PMID:
3124130
36.

Quantitative differences among various proteins as blocking agents for ELISA microtiter plates.

Vogt RF Jr, Phillips DL, Henderson LO, Whitfield W, Spierto FW.

J Immunol Methods. 1987 Jul 16;101(1):43-50.

PMID:
3611792
37.

Contrasting short- and long-term effects of weight loss on lipoprotein levels.

Follick MJ, Abrams DB, Smith TW, Henderson LO, Herbert PN.

Arch Intern Med. 1984 Aug;144(8):1571-4.

PMID:
6466014
38.

Effects of propranolol on blood lipids and lipoproteins in myocardial infarction.

Shulman RS, Herbert PN, Capone RJ, McClure D, Hawkins CM, Henderson LO, Saritelli A, Campbell J.

Circulation. 1983 Jun;67(6 Pt 2):I19-21.

PMID:
6851036
39.

Exercise, diet, or physical characteristics as determinants of HDL-levels in endurance athletes.

Thompson PD, Lazarus B, Cullinane E, Henderson LO, Musliner T, Eshleman R, Herbert PN.

Atherosclerosis. 1983 Mar;46(3):333-9.

PMID:
6405759
40.

Radioimmunoassay of apolipoprotein a-ii.

Musliner TA, Garner PA, Henderson LO, Herbert PN.

Arteriosclerosis. 1982 Mar-Apr;2(2):160-9.

PMID:
6802116
41.

Quantitative determination of human plasma apolipoprotein A-I by laser immunonephelometry.

Rosseneu M, Vercaemst R, Vinaimont N, Van Tornout P, Henderson LO, Herbert PN.

Clin Chem. 1981 Jun;27(6):856-9.

42.

Minimal within-day variation of high density lipoprotein cholesterol and apolipoprotein A-I levels in normal subjects.

Henderson LO, Saritelli AL, LaGarde E, Herbert PN, Shulman RS.

J Lipid Res. 1980 Sep;21(7):953-5.

43.

Acute effects of prolonged exercise on serum lipids.

Thompson PD, Cullinane E, Henderson LO, Herbert PN.

Metabolism. 1980 Jul;29(7):662-5.

PMID:
7382830
44.

Artifactual reduction of high-density lipoprotein cholesterol estimates after dextran sulfate--Mg2+ precipitation.

Henderson LO, LaGarde E, Herbert PN.

Am J Clin Pathol. 1980 May;73(5):664-8.

PMID:
6155066
45.

Plasma-triglycerides do not regulate high-density lipoprotein concentrations.

Herbert PN, Henderson LO.

Lancet. 1979 Jun 30;1(8131):1368-70.

PMID:
87831
46.

Abnormal concentration and anomalous distribution of apolipoprotein A-I in Tangier disease.

Henderson LO, Herbert PN, Fredrickson DS, Heinen RJ, Easterling JC.

Metabolism. 1978 Feb;27(2):165-74.

PMID:
622047

Supplemental Content

Loading ...
Support Center